| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2018 | CRL Charles River Laboratories International, Inc. | Girshick Birgit65 | Corporate Executive VP | Sell | 3,978 | $119.90 | $476,962.20 | -17.3% | |
| Jul 17, 2018 | CRL Charles River Laboratories International, Inc. | Molho Davide | President &COO | Sell | 11,126 | $120.00 | $1,335,120.00 | -24.8% | |
| Jul 16, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 15,000 | $5.68 | $85,248.50 | - | |
| Jul 11, 2018 | MYGN Myriad Genetics Inc | Henderson John T65 | Director | Sell | 30,000 | $42.06 | $1,261,785.00 | -16.7% | |
| Jul 11, 2018 | MYGN Myriad Genetics Inc | Capone Mark Christopher | President &C.e.o. | Sell | 80,000 | $41.00 | $3,280,000.00 | -10.7% | |
| Jul 11, 2018 | MYGN Myriad Genetics Inc | Marsh Richard M | E.v.p., General Counsel | Sell | 70,672 | $42.88 | $3,030,220.00 | -22.1% | |
| Jul 11, 2018 | OPK Opko Health, Inc. | Fishel Robert Scott | Director | Buy | 2,500 | $6.00 | $14,991.25 | - | |
| Jul 11, 2018 | MYGN Myriad Genetics Inc | Lanchbury Jerry S81 | Chief Scientific Officer | Sell | 50,000 | $43.34 | $2,167,040.00 | -15.3% | |
| Jul 6, 2018 | VCYT Veracyte, Inc. | Hall Christopher M | President And COO | Sell | 50,000 | $9.99 | $499,387.45 | -43.5% | |
| Jul 3, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $4.75 | $47,500.50 | - | |
| Jul 2, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 5,348 | $111.34 | $595,462.26 | - | |
| Jul 2, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 5,005 | $110.80 | $554,552.38 | - | |
| Jul 2, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 5,471 | $111.11 | $607,864.84 | - | |
| Jul 2, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 2,775 | $111.55 | $309,539.90 | - | |
| Jul 2, 2018 | EXAS Exact Sciences Corp | Coward D Scott77 | SVP And General Counsel | Sell | 2,135 | $59.10 | $126,176.36 | -2.8% | |
| Jul 2, 2018 | CDNA Caredx, Inc. | Nelles Mitchell J | Chief Operating Officer | Sell | 39,649 | $12.48 | $494,910.71 | -31.3% | |
| Jul 2, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 6,401 | $110.53 | $707,471.54 | - | |
| Jun 29, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 7,720 | $4.71 | $36,335.20 | - | |
| Jun 29, 2018 | NEO Neogenomics Inc | Shovlin Robert J. | President, Clinical Services | Sell | 12,941 | $13.12 | $169,785.92 | -24.5% | |
| Jun 29, 2018 | FONR Fonar Corp | Damadian Raymond V | Treasurer | Sell | 1,240 | $26.52 | $32,886.36 | -0.5% | |
| Jun 28, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 20,000 | $4.68 | $93,600.00 | +0.2% | |
| Jun 27, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $4.75 | $47,500.00 | +0.3% | |
| Jun 27, 2018 | FONR Fonar Corp | Damadian Raymond V | Treasurer | Sell | 1,240 | $27.37 | $33,932.60 | -0.5% | |
| Jun 25, 2018 | CRL Charles River Laboratories International, Inc. | Massaro George66 | Director | Sell | 3,230 | $114.05 | $368,380.59 | -0.8% | |
| Jun 25, 2018 | CRL Charles River Laboratories International, Inc. | Massaro George66 | Director | Sell | 300 | $115.55 | $34,665.00 | -0.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.